301129.SZ(301129.SZ)
301129.SZ
No analyst ratings available
No analyst price targets available for 301129.SZ
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $811M | $931M |
| Low | $811M | $931M |
| High | $811M | $931M |
| EBITDA Avg | $242M | $277M |
| Low | $242M | $277M |
| High | $242M | $277M |
| EBIT Avg | $213M | $245M |
| Low | $213M | $245M |
| High | $213M | $245M |
| Net Income Avg | $192M | $223M |
| Low | $192M | $223M |
| High | $192M | $223M |
| EPS Avg | $1.41 | $1.64 |
| Low | $1.41 | $1.64 |
| High | $1.41 | $1.64 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $17M | $17M | $17M | $17M | $17M | $17M | $18M |
| Low | $17M | $17M | $17M | $17M | $17M | $17M | $18M |
| High | $17M | $17M | $17M | $17M | $17M | $17M | $18M |
| EBITDA Avg | $5M | $5M | $5M | $5M | $5M | $5M | $5M |
| Low | $5M | $5M | $5M | $5M | $5M | $5M | $5M |
| High | $5M | $5M | $5M | $5M | $5M | $5M | $5M |
| EBIT Avg | $4M | $4M | $4M | $5M | $5M | $5M | $5M |
| Low | $4M | $4M | $4M | $5M | $5M | $5M | $5M |
| High | $4M | $4M | $4M | $5M | $5M | $5M | $5M |
| Net Income Avg | $197M | $15M | $197M | $20M | $13M | $20M | $244M |
| Low | $197M | $15M | $197M | $20M | $13M | $20M | $244M |
| High | $197M | $15M | $197M | $20M | $13M | $20M | $244M |
| EPS Avg | $1.47 | $0.11 | $1.47 | $0.15 | $0.10 | $0.15 | $1.82 |
| Low | $1.47 | $0.11 | $1.47 | $0.15 | $0.10 | $0.15 | $1.82 |
| High | $1.47 | $0.11 | $1.47 | $0.15 | $0.10 | $0.15 | $1.82 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |